# US 2006/0040025 A1 · Milk protein isolate and method for preparing same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0040025 A1
- Document ID: US20060040025A1
- Status: Published application
- Kind: A1
- Application number: 10/519,131
- Filed: 2003-06-30
- Published: 2006-02-23
- Earliest claimed: 2002-07-02
- Assignees: Compagnie Laitiere Europeenne
- Inventors: Jerome Souppe
- Web page: https://patentgrep.com/patent/US20060040025A1

## CPC

- A23C 9/1465: {Chromatographic separation of protein or lactose fraction; Adsorption of protein or lactose fraction followed by elution}
- A23J 1/20: from milk, e.g. casein (curds or cheese A23C); from whey
- A23J 1/205: {from whey, e.g. lactalbumine}
- A23L 33/19: Dairy proteins
- A61K 38/1709: {from mammals}
- A61K 38/40: Transferrins, e.g. lactoferrins, ovotransferrins
- A61P 19/00: Drugs for skeletal disorders
- A23C: DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF (preservation thereof A23B11/00)
- A23J: PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to a novel process for isolating milk proteins from milk or from whey; its subject is also a milk protein fraction obtained by this process and its use for the preparation of pharmaceutical or food compositions.

## Claims

### Claim 1

A process for isolating milk proteins from milk or whey comprising the following steps:
a) the milk or the whey is sterilized and defatted;
b) the milk fraction derived from step a) is passed over a cation-exchange resin conditioned in an elution column;
c) the fraction retained on the resin is eluted with an aqueous salt solution;
d) the eluate resulting from step c) is desalted and sterilized and wherein
α) the cation-exchange resin is a resin grafted onto strong acid functional groups;
the parameter BV denoting the ratio of the volume of raw material to the volume of wet resin in the column,
the parameter SV denoting the ratio of the rate of feeding the column to the volume of wet resin in the column,
the parameter LV denoting the ratio of the rate of feeding the column to the section of the column,
β) during step b), the binding parameters have the following values:
BVf is between 5 and 400;
SVf is between 2 and 40 h−1;
LVf is greater than or equal to 1 m/h and less than or equal to 5 m/h.
γ) during step c), the elution parameters have the following values:
BVe is between 1.5 and 7;
LVe is less than 1 m/h.

### Claim 2 (depends on 1)

The process as claimed in claim 1, wherein the starting material is cows' milk.

### Claim 3 (depends on 1)

The process as claimed in claim 1, wherein the starting material is a casein acid whey.

### Claim 4 (depends on 1)

The process as claimed in claim 1, wherein the cation-exchange resin is a resin grafted by acid functional groups with a pKa≦2 having an ion-exchange capacity of between 200 and 1000 μE/ml.

### Claim 5 (depends on 4)

The process as claimed in claim 4, wherein the resin is grafted by sulfonate salt or sulfonic acid functional groups.

### Claim 6 (depends on 5)

The process as claimed in claim 5, wherein the resin is grafted by propyl sulfonate or propylsulfonic functional groups.

### Claim 7 (depends on 1)

The process as claimed in claim 1, wherein the particle size of the resin is between 100 μm and 900 μm.

### Claim 8 (depends on 1)

The process as claimed in claim 1, wherein during step b) of binding of the raw material, one or more of the following conditions are met:
BVf is between 80 and 150;
SVf is between 5 and 40 h−1;
LVf is between 3 and 4.3 m/h.

### Claim 9 (depends on 1)

The process as claimed in claim 1, wherein the following conditions are met
during step b):
BVf is between 80 and 120;
SVf is between 8 and 15 h−1;
LVf is between 3 and 4.8 m/h.
during step c):
BVe is between 3 and 7;
LVe is less than 1 m/h.

### Claim 10 (depends on 1)

The process as claimed in claim 1, wherein during step b), the resin is conditioned in a column whose temperature is kept between 2 and 15° C.

### Claim 11 (depends on 1)

The process as claimed in claim 1, wherein during step c) for elution of the bound proteins, at least one of the following conditions is met:
BVe is between 3 and 5;
LVe is less than 0.5 m/h.

### Claim 12 (depends on 1)

The process as claimed in claim 1, wherein during step c), the resin is conditioned in a column whose temperature is kept between 2 and 15° C.

### Claim 13 (depends on 1)

The process as claimed in claim 1, wherein the aqueous saline solution used for carrying out the invention is a solution of a chloride of an alkali metal chosen from K+, Na+, Ca+, Mg+.

### Claim 14 (depends on 12)

The process as claimed in claim 12, wherein the aqueous saline solution is an aqueous sodium chloride solution.

### Claim 15 (depends on 14)

The process as claimed in claim 14, wherein the aqueous saline solution has a concentration of between 2 and 25% by weight of salt per weight of liquid.

### Claim 16 (depends on 14)

The process as claimed in claim 14, wherein the aqueous saline solution has an ionic strength of between 1 and 2 M.

### Claim 17 (depends on 1)

The process as claimed in claim 1, wherein the pH of the aqueous saline solution for elution is between 6 and 7.

### Claim 18 (depends on 1)

The process as claimed in claim 1, wherein preceding claims, characterized in that the desalting is carried out by ultrafiltration and diafiltration.

### Claim 19 (depends on 18)

The process as claimed in claim 18, wherein the ultrafiltration and diafiltration treatments are carried out until a permeate having a conductivity of less than 15 mS is obtained.

### Claim 20 (depends on 1)

The process as claimed in claim 1, wherein the sterilization is carried out by microfiltration.

### Claim 21 (depends on 1)

The process as claimed in claim 1, wherein the desalted and sterilized product is dried so as to obtain the milk fraction derived from the process of the invention in the form of a powder.

### Claim 22 (depends on 1)

A milk protein fraction, obtained by the process according to claim 1.

### Claim 23

A milk protein fraction, having the following characteristics:
a protein content of greater than 90%,
a mineral salt content of less than 1%,
a fat content of less than 1%,
a lactose content of less than 1%,
a moisture content of less than 5%,
a lactoferrin content of less than 80%,
a pH in solution at 2% of between 6 and 7.5,
a UV-visible spectrophotometric purity defined by an OD412/OD280 ratio <0.15,
contains at least 1% of proteins having an isoelectric point greater than or equal to 8,
the percentages being given by weight relative to the weight of dry matter content of the milk fraction.

### Claim 24 (depends on 23)

The milk protein fraction as claimed in claim 23, wherein it corresponds to at least one of the following characteristics:
a protein content of greater than 95%,
a mineral salt content of less than 0.5%,
a fat content of less than 0.5%,
a lactose content of less than 0.5%,
a moisture content of less than 4%,
a lactoferrin content of less than 80%,
a pH in solution at 2% of between 6 and 7.2,
a UV-visible spectrophotometric purity defined by an OD412/OD280 ratio <0.1,
contains at least 1% of proteins having an isoelectric point of between 8.2 and 8.7.

### Claim 25 (depends on 23)

The milk protein fraction as claimed in claim 23 it is derived from cows' milk.

### Claim 26 (depends on 25)

The milk protein fraction as claimed in claim 25, comprising at least 40% of proteins having an isoelectric point greater than or equal to 8.

### Claim 27 (depends on 25)

The milk protein fraction as claimed in claim 25 having a lactoferrin content greater than or equal to 30% and a lactoperoxidase activity greater than or equal to 120 ABTS units per mg of isolate.

### Claim 28 (depends on 22)

The milk protein fraction as claimed in claim 22 which is derived from a casein acid whey.

### Claim 29 (depends on 22)

A combination of a milk protein fraction according to claim 22 with calcium.

### Claim 30 (depends on 29)

The combination as claimed in claim 29, additionally including vitamin D.

### Claim 31

A food composition, comprising a milk protein fraction according to.

### Claim 32 (depends on 22)

A dietary kit comprising a powder of milk protein fraction as claimed in claim 22.

### Claim 33 (depends on 22)

A dietary milk prepared from a milk protein fraction as claimed in claim 22.

### Claim 34 (depends on 22)

A food intended for the prevention of a pathology selected from: growth retardation, osteoporosis, bone fragility, bone fractures, rheumatism, osteoarthritis, periodontal diseases, and intestinal barrier deficiency, said food being prepared from a milk protein fraction as claimed in claim 22.

### Claim 35 (depends on 22)

A food intended to promote the growth of osteoblasts and/or of intestinal cells and/or to inhibit the growth of preosteoclasts, said food being prepared from a milk protein fraction as claimed in claim 22.

### Claim 36

A pharmaceutical composition, comprising at least one milk protein fraction as claimed in and a pharmaceutically acceptable carrier.

### Claim 37 (depends on 22)

A medicament intended for the prevention and/or treatment of a pathology selected from: growth retardation, osteoporosis, bone fragility, bone fractures, rheumatism, osteoarthritis, periodontal diseases, and intestinal barrier deficiency, said medicament comprising a milk protein fraction as claimed in claim 22.

### Claim 38 (depends on 22)

The use of a milk protein fraction as claimed in claim 22, for the preparation of a medicament intended to improve the absorption of calcium in the body.

### Claim 39 (depends on 22)

A medicament intended to promote the growth of osteoblasts and/or of intestinal cells and/or to inhibit the growth of preosteoclasts, said medicament comprising a milk protein fraction as claimed in claim 22.

### Claim 40 (depends on 22)

A hygiene product, comprising at least one milk protein fraction as claimed in claim 22.
